L. reuteri
A specific probiotic species with genuinely strain-specific effects. Worth separating from general probiotics because in this field the strain is the drug — two products both saying 'L. reuteri' can behave completely differently.
How L. reuteri actually works
Produces reuterin, an antimicrobial that suppresses gram-negative organisms including H. pylori, and adheres to intestinal mucus to compete for binding sites. The strain determines the effect entirely: DSM 17938 is the colic strain, ATCC PTA 6475 the immunomodulatory one. Rodent work suggests vagal signalling to oxytocin release, which is the basis of the current online interest and has no human confirmation.
L. reuteri quick facts
| Suggested dose | Typically 1–10 billion CFU daily. Match the strain to the outcome you want — DSM 17938 and ATCC PTA 6475 are studied for different things. |
| How often | Daily |
| Who it's for | Post-antibiotic recovery, H. pylori protocols, infant colic. |
✅ Clinically validated
- DSM 17938 has good randomised evidence for reducing crying time in breastfed infants with colic — one of the better-supported probiotic indications there is.
- Used as an adjunct in Helicobacter pylori eradication, several trials report improved tolerability and modestly improved eradication rates.
- Trials in adults for general wellbeing outcomes are far weaker than the marketing suggests.
📊 Correlative data
- L. reuteri appears to be less prevalent in modern Western guts than in historical or non-industrialised populations, which is the observation the current interest is built on.
🧪 Theoretical / extrapolated benefits
- Rodent work links L. reuteri to oxytocin signalling via the vagus, with downstream effects reported on social behaviour, wound healing and testicular size. This is the basis of the 'reuteri yoghurt' trend and it has NOT been demonstrated in humans.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Match the strain to the goal — a product labelled only 'L. reuteri' with no strain designation tells you nothing usable. 1–10 billion CFU daily, and probiotics generally need continued use because colonisation is transient in most adults. The home-fermented 'reuteri yoghurt' protocol extrapolates mouse hormone data to humans and adds a real contamination risk at the long fermentation times used. Immunocompromised people should not take live probiotics without medical advice — bacteraemia is rare but documented.
L. reuteri — safety & side effects
- Gas and bloating early on. Some strains produce histamine-lowering effects; others do the opposite, so strain identity matters.
- Bloodstream infection has occurred in immunocompromised patients, in critical illness, and in people with central venous catheters. That is the one contraindication here that is not theoretical. Otherwise: expect one to two weeks of gas and bloating while things settle.
- Home-fermented high-count yoghurts are popular and are not a controlled product — the counts and the contamination risk are both unknown.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
Where to get L. reuteri
Find L. reuteri on iHerb →Get the complete breakdown for L. reuteri — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside L. reuteri
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Anaemia is the commonest sign of a gut absorbing badly |
| Ferritin | Iron is the first thing malabsorption takes |
| Vitamin B12 | The second thing, and the one with permanent consequences |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Separates inflammatory bowel disease from IBS |
The Gut Health & Absorption panel covers these in one order — 11 markers, $208.80 with the discount applied.
Check results you already have → · All 102 markers A–Z
L. reuteri — frequently asked questions
What is L. reuteri?
A specific probiotic species with genuinely strain-specific effects. Worth separating from general probiotics because in this field the strain is the drug — two products both saying 'L. reuteri' can behave completely differently.
What is the suggested dose of L. reuteri?
Typically 1–10 billion CFU daily. Match the strain to the outcome you want — DSM 17938 and ATCC PTA 6475 are studied for different things. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
What are the researched benefits of L. reuteri?
DSM 17938 has good randomised evidence for reducing crying time in breastfed infants with colic — one of the better-supported probiotic indications there is.
Who is L. reuteri for?
Post-antibiotic recovery, H. pylori protocols, infant colic.
Where can I buy L. reuteri?
Coach Cam sources L. reuteri from vetted, top-rated brands on iHerb — use the buy link on this page.
Build your foundation with Coach Cam
The full Supplement Vault — 350 products across 14 categories with clinical, correlative & theoretical evidence, plus my Thorne partner links — lives inside the Academy alongside 237 peptides.
Join the Academy — $10/mo →